Using patients' own cells, Mayo researchers used a special cocktail of proteins to train them to become heart-like and successfully introduced them to the individuals' cardiac tissue that had been damaged by disabling heart attacks. All participants in this Phase II trial improved, both in the pumping ability of their hearts and in their ability to walk greater distances with comfort. A major advancement from Andre Terzic, M.D., Ph.D., and the Center for Regenerative Medicine. Watch a great video on this story.
Tags: cardiology, Center for Regenerative Medicine, Findings, heart attack, heart failure, heart repair, Innovations, Mayo Clinic, People, Progress Updates, regenerative medicine, stem cells, Uncategorized